Laser Ablation is Superior to TACE in Large-Sized Hepatocellular Carcinoma: A Pilot Case-Control Study
Limited therapies are available for large (≥40 mm) unresectable hepatocellular carcinoma (HCC). Currently, the standard treatment with transarterial chemoembolisation (TACE) is unsatisfactory with high recurrence rate and limited effect on survival. Laser Ablation (LA) has emerged as a relatively new technique characterized by high efficacy and good safety. This study is aimed to evaluate the efficacy of LA in comparison to TACE in patients with large HCC.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063